- Company Is Stepping up Its Efforts in China's Pharmaceutical Industry -

TOKYO, Aug. 1, 2022 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has established a Healthcare Branch in Shanghai to strengthen its efforts in China's pharmaceutical industry, and this new branch opened for business on July 1.

Logo: https://kyodonewsprwire.jp/img/202207284436-O1-Ubnp6zGP

Photo: Staff of NX China's Healthcare Branch https://kyodonewsprwire.jp/prwfile/release/M103866/202207284436/_prw_PI2lg_D2ycmEMc.jpg

China is the world's second largest pharmaceutical market after the United States, and the aging of its population and the uptrend in its per capita income are expected to drive further growth.

To address the needs of a rapidly expanding pharmaceutical market and provide customers with high-quality and consistent pharmaceutical logistics services that meet their quality standards, NX China established the Healthcare Branch in Shanghai and staffed it with personnel having considerable know-how in pharmaceutical logistics to centrally handle sales development and quality control.

The Nippon Express Group will continue meeting the diversifying needs of customers around the world to contribute to society through logistics.

- Profile of new branch
Name: Nippon Express (China) Co., Ltd., Healthcare Branch
Location: 11F, Shanghai Mart, 2299 West Yan'an Road, Shanghai

- Description of business
Sales development and support for the pharmaceutical industry, quality control, development/management of cold storage containers, packaging materials and refrigerated transport equipment for pharmaceuticals, etc. in China

Nippon Express website: https://www.nipponexpress.com/

Nippon Express Group's official LinkedIn account:
https://www.linkedin.com/company/nippon-express-group/

[편집자주] 해당 기사는 자료 제공사에서 제공한 것으로, 팜뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 알려 드립니다.

출처 : PR Newswire 보도자료

개의 댓글

0 / 400
댓글 정렬
BEST댓글
BEST 댓글 답글과 추천수를 합산하여 자동으로 노출됩니다.
댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글수정
댓글 수정은 작성 후 1분내에만 가능합니다.
/ 400

내 댓글 모음

이 시각 추천뉴스
랭킹뉴스